DEL PRATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 68.669
AS - Asia 28.462
EU - Europa 23.727
SA - Sud America 4.305
Continente sconosciuto - Info sul continente non disponibili 913
AF - Africa 751
OC - Oceania 50
Totale 126.877
Nazione #
US - Stati Uniti d'America 61.977
CN - Cina 8.252
SG - Singapore 8.091
IT - Italia 6.384
CA - Canada 6.235
HK - Hong Kong 5.343
PL - Polonia 3.893
BR - Brasile 3.591
SE - Svezia 2.741
VN - Vietnam 2.177
BG - Bulgaria 2.031
DE - Germania 1.706
UA - Ucraina 1.432
KR - Corea 1.243
GB - Regno Unito 1.138
TR - Turchia 1.039
FR - Francia 1.035
RU - Federazione Russa 1.000
FI - Finlandia 901
CH - Svizzera 656
IN - India 464
JP - Giappone 425
BD - Bangladesh 268
AT - Austria 237
AR - Argentina 216
IQ - Iraq 201
CI - Costa d'Avorio 149
MX - Messico 140
EC - Ecuador 130
ID - Indonesia 129
SA - Arabia Saudita 125
NL - Olanda 122
ZA - Sudafrica 119
PK - Pakistan 101
BE - Belgio 92
SN - Senegal 92
VE - Venezuela 90
MA - Marocco 85
CO - Colombia 81
UZ - Uzbekistan 78
ES - Italia 73
JM - Giamaica 69
IR - Iran 57
IE - Irlanda 55
EG - Egitto 54
IL - Israele 50
PY - Paraguay 50
NG - Nigeria 46
CR - Costa Rica 45
MY - Malesia 44
PH - Filippine 44
UY - Uruguay 44
JO - Giordania 42
CL - Cile 41
KE - Kenya 39
AU - Australia 38
PE - Perù 38
NP - Nepal 34
DZ - Algeria 32
LT - Lituania 30
TN - Tunisia 30
NI - Nicaragua 29
BJ - Benin 26
CZ - Repubblica Ceca 24
EU - Europa 23
TT - Trinidad e Tobago 23
TW - Taiwan 23
GR - Grecia 22
GT - Guatemala 22
HN - Honduras 22
KZ - Kazakistan 22
AE - Emirati Arabi Uniti 21
AZ - Azerbaigian 21
BB - Barbados 21
OM - Oman 21
PS - Palestinian Territory 21
PT - Portogallo 21
PA - Panama 20
DO - Repubblica Dominicana 18
NO - Norvegia 18
RO - Romania 17
KG - Kirghizistan 16
BO - Bolivia 15
LB - Libano 14
SV - El Salvador 13
AL - Albania 12
DK - Danimarca 12
GE - Georgia 12
TH - Thailandia 12
BY - Bielorussia 11
HU - Ungheria 11
PR - Porto Rico 11
RS - Serbia 11
ET - Etiopia 10
NZ - Nuova Zelanda 10
SY - Repubblica araba siriana 10
QA - Qatar 9
AM - Armenia 8
BH - Bahrain 8
HR - Croazia 8
Totale 125.812
Città #
Woodbridge 6.658
Ashburn 6.240
Hong Kong 5.291
Ann Arbor 5.212
Montreal 4.669
Singapore 4.546
Fairfield 4.435
Houston 4.423
San Jose 3.241
Chandler 2.852
Dallas 2.411
Milan 2.368
Sofia 2.016
Jacksonville 2.005
Seattle 1.838
Santa Clara 1.621
Wilmington 1.605
Shanghai 1.592
Cambridge 1.504
Beijing 1.486
Hefei 1.310
New York 1.280
Ottawa 1.271
Seoul 1.215
Council Bluffs 1.166
Boardman 927
Princeton 918
Lawrence 783
Nanjing 717
Medford 678
Lauterbourg 677
Los Angeles 669
Bern 628
Izmir 587
Serra 525
Ho Chi Minh City 503
Des Moines 486
Tokyo 392
Hanoi 377
Jüchen 350
Dearborn 346
Istanbul 335
Buffalo 323
San Diego 297
Nanchang 292
Rome 290
São Paulo 274
Dong Ket 254
Boulder 253
Redondo Beach 245
Chicago 207
The Dalles 206
Columbus 194
London 187
Vienna 172
Redwood City 171
Frankfurt am Main 170
Kunming 169
Shenyang 156
Florence 153
Abidjan 148
Pisa 144
Changsha 139
Falls Church 138
Bremen 134
Munich 132
Helsinki 123
Rio de Janeiro 123
Ogden 116
Hebei 113
Tianjin 101
Jiaxing 98
Lancaster 96
Orem 93
Dakar 91
San Francisco 90
Washington 90
Brussels 89
Baghdad 88
Nuremberg 88
Toronto 87
Grafing 84
Belo Horizonte 80
Düsseldorf 80
Norwalk 79
Warsaw 78
Brasília 77
Guangzhou 76
Haiphong 76
Phoenix 71
Tashkent 70
Brooklyn 68
Curitiba 65
Hangzhou 63
Chennai 62
Fuzhou 62
Manchester 61
Turku 60
Da Nang 59
Dhaka 59
Totale 89.817
Nome #
RISULTATI AD UN ANNO NEL TRAPIANTO SIMULTANEO DI PANCREAS-RENE: LA SCELTA PREEMPTIVE E’ VANTAGGIOSA? 4.508
ACE-INHIBITION PROTECTS PANCREATIC HUMAN ISLETS FROM GLUCOTOXICITY AND IMPROVES THE FUNCTION OF ISLETS FROM TYPE 2 DIABETIC PATIENTS 4.152
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 835
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 302
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 298
Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease 290
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids 289
Altered Visual Plasticity in Morbidly Obese Subjects 277
Gestational diabetes, inflammation, and late vascular disease 272
G-protein-coupled receptor 40 (GPR40) expression in human pancreatic 267
Activation of the hexosamine pathway leads to phosphorylation of IRS-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mTOR insulin biosynthetic pathway in RIN pancreatic {beta}-cells 258
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes 257
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 256
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes 255
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 249
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects 249
Insulin resistance in Cushing's syndrome. 246
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. 239
Absence of islet alpha cell function in pancreatectomized patients. 238
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 236
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 235
Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry 234
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 232
Prevalence and risk factors for gestational diabetes assessed by universal screening 232
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 231
Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients 231
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 231
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 230
The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats 229
Brain effect of bariatric surgery in people with obesity 227
Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. 227
The effects of bariatric surgery on the brain glucose metabolism and its biological mediators: an insight from dynamic 18F-FDG PET/CT study 224
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality. A study in Tuscany, Italy, over years 2004-2011 221
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients 221
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy 220
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 218
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. 218
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. 218
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 218
Selective screening for GDM in Italy: application and effectiveness of National Guidelines 217
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 217
Exenatide modulates visual cortex responses 217
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 215
A SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 215
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. 214
Functional and survival analysis of isolated human islets 213
Basal insulin and cardiovascular and other outcomes in dysglycemia. 212
The relationship between alanine and ketone body in vivo 211
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 211
The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. 210
What therapy do our NIDDM patients need? Insulin releasers 210
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up 210
The vascular effects of doxazosin in hypertension complicated by metabolic syndrome 209
Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress 207
Glucagon-like peptide-1 (GLP-1) secretion in women with gestational diabetes mellitus during and after pregnancy 207
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 207
Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion 206
ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS. 206
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 206
Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents 205
Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. 205
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 204
Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 204
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program 203
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management 203
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects 203
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 203
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 202
Optimal therapy of type 2 diabetes: a controversial challenge 202
A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells 202
Beta- and alpha-cell dysfunction in type 2 diabetes 201
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 201
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 201
Hyperglucagonemia and insulin-mediated glucose metabolism 200
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. 200
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. 200
Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation 199
PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY 198
Oxidative stress in isolated human pancreatic islets: possible role of frataxin 198
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers - A randomized prospective trial versus traditional fiberglass cast 198
Early vs. standard screening and treatment of gestational diabetes in high-risk women – An attempt to determine relative advantages and disadvantages 198
SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED, PILOT STUDY COMPARING CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 197
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 197
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance 196
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? 196
Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion 195
Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 195
Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses. 195
The beneficial effects of pancreas transplant alone on diabetic nephropathy 194
A call to action - the UN Resolution on diabetes 194
A common polymorphism in the ccl2 gene regulatory region affects mcp-1 gene expression and function of isolated non-diabetic and type 2 diabetic islets 193
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin 193
Insulin discovery: A pivotal point in medical history 193
Is there a local "incretin system" in human pancreatic islets? 192
Glucose transporter 2 gene polymorphisms and beta-cell function in isolated human pancreatic islets 192
Is maternal educational level a risk factor for gestational diabetes in Caucasian women? 192
Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome 192
Altered autophagy in the pancreatic beta cells of human type 2 diabetes 192
Pre-pregnancy obesity, gestational diabetes or gestational weight gain: Which is the strongest predictor of pregnancy outcomes? 192
Type 2 diabetes mellitus: focus on new treatments and special populations 191
Totale 30.601
Categoria #
all - tutte 345.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 345.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.528 0 0 186 543 1.596 1.183 213 441 297 302 462 2.305
2022/20237.982 1.152 730 381 800 1.086 1.161 86 685 1.253 84 470 94
2023/202416.714 1.376 1.129 1.122 568 1.230 1.295 172 192 162 8.525 151 792
2024/202521.686 131 916 274 1.145 1.266 1.718 2.029 1.615 2.205 3.211 2.681 4.495
2025/202623.599 1.601 3.404 3.248 2.175 1.939 2.345 3.253 1.108 1.133 2.248 701 444
2026/20276.056 532 1.839 3.685 0 0 0 0 0 0 0 0 0
Totale 126.877